William Haney
13Patents
5h-index
15Co-inventors
63Inventor score
Filing activity: Jan 15, 1976 → Nov 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4042327A | Ion-pairing chromatography | Emerging Cross-Sectional Technologies | 12 | Expired |
| US11834506B2 | Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer | Chemistry; Metallurgy | 9 | Active |
| US11787864B2 | Heterodimeric Fc-fused proteins | Chemistry; Metallurgy | 9 | Active |
| US11939384B1 | Antibody variable domains targeting the NKG2D receptor | Chemistry; Metallurgy | 7 | Active |
| US11884733B2 | Antibody variable domains targeting the NKG2D receptor | Chemistry; Metallurgy | 6 | Active |
| US11884732B2 | Proteins binding HER2, NKG2D and CD16 | Chemistry; Metallurgy | 3 | Active |
| US12384851B2 | Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12129300B2 | Antibody variable domains targeting the NKG2D receptor | Chemistry; Metallurgy | 0 | Active |
| US12264200B2 | Antibody variable domains targeting the NKG2D receptor | Chemistry; Metallurgy | 0 | Active |
| US12384847B2 | Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen | Chemistry; Metallurgy | 0 | Active |
| US12378318B2 | Proteins binding NKG2D, CD16 and a tumor-associated antigen | Chemistry; Metallurgy | 0 | Active |
| US12275791B2 | Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12215157B2 | Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.